These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 25550859)
1. PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells. Zhang Y; Wang SJ; Han ZH; Li YQ; Xue JH; Gao DF; Wu XS; Wang CX Int J Clin Exp Pathol; 2014; 7(11):8112-7. PubMed ID: 25550859 [TBL] [Abstract][Full Text] [Related]
2. [The action of PI3K/AKT during genistein promoting the activity of eNOS]. Zheng FL; Zhao JH; Zhang HP Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):327-31. PubMed ID: 22801313 [TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide facilities production of nitric oxide via the Akt/endothelial nitric oxide synthases signaling pathway to protect human umbilical vein endothelial cells from injury by angiotensin II. Cui J; Zhuang S; Qi S; Li L; Zhou J; Zhang W; Zhao Y; Qi N; Yin Y; Huang L Mol Med Rep; 2017 Nov; 16(5):6255-6261. PubMed ID: 28849094 [TBL] [Abstract][Full Text] [Related]
4. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway. Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463 [TBL] [Abstract][Full Text] [Related]
5. [Effects and related mechanism of flavone from Galium verum L on peroxide induced oxidative injury in human umbilical vein endothelial cells]. Dong JM; Ma YL; Zhang ZY; Li R; Zhu YL; Ma L Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jul; 44(7):610-5. PubMed ID: 27530947 [TBL] [Abstract][Full Text] [Related]
6. Effect of ghrelin on angiotensin II induced human umbilicus vein endothelial cell oxidative stress and endothelial cell injury. Deng B; Fang L; Chen X; Chen M; Xie X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1037-47. PubMed ID: 21051828 [TBL] [Abstract][Full Text] [Related]
7. [Effect of rosiglitazone on NO and eNOS via PI3K/PKB signal pathways in cultured human umbilical vein endothelial cells]. Wu J; Lei MX; Xie XY; Feng XL Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):824-30. PubMed ID: 18007078 [TBL] [Abstract][Full Text] [Related]
8. Baicalin attenuates angiotensin II-induced endothelial dysfunction. Wei X; Zhu X; Hu N; Zhang X; Sun T; Xu J; Bian X Biochem Biophys Res Commun; 2015 Sep; 465(1):101-7. PubMed ID: 26239661 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways. Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159 [TBL] [Abstract][Full Text] [Related]
10. Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Ahsan A; Han G; Pan J; Liu S; Padhiar AA; Chu P; Sun Z; Zhang Z; Sun B; Wu J; Irshad A; Lin Y; Peng J; Tang Z Apoptosis; 2015 Dec; 20(12):1563-76. PubMed ID: 26404526 [TBL] [Abstract][Full Text] [Related]
11. Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway. Shi F; Wang YC; Zhao TZ; Zhang S; Du TY; Yang CB; Li YH; Sun XQ PLoS One; 2012; 7(7):e40365. PubMed ID: 22808143 [TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin inhibits angiotensin II induced cardiomyocyte hypertrophy in vitro via activating PI3K/Akt-eNOS pathway]. Wen Y; Ma YX; Zhang XJ; Hong LF; Feng DY; Lu ZH Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):436-40. PubMed ID: 19781221 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2. Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965 [TBL] [Abstract][Full Text] [Related]
14. Lespedeza cuneata protects the endothelial dysfunction via eNOS phosphorylation of PI3K/Akt signaling pathway in HUVECs. Lee JH; Parveen A; Do MH; Lim Y; Shim SH; Kim SY Phytomedicine; 2018 Sep; 48():1-9. PubMed ID: 30195866 [TBL] [Abstract][Full Text] [Related]
15. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases. Ning WH; Zhao K Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Namkoong S; Lee SJ; Kim CK; Kim YM; Chung HT; Lee H; Han JA; Ha KS; Kwon YG; Kim YM Exp Mol Med; 2005 Dec; 37(6):588-600. PubMed ID: 16391520 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthesis-promoting effects of valsartan in human umbilical vein endothelial cells via the Akt/adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway. Zhao Y; Wang L; He S; Wang X; Shi W Bosn J Basic Med Sci; 2017 May; 17(2):132-137. PubMed ID: 28178430 [TBL] [Abstract][Full Text] [Related]
19. Propofol prevents human umbilical vein endothelial cell injury from Ang II-induced apoptosis by activating the ACE2-(1-7)-Mas axis and eNOS phosphorylation. Zhang L; Wang J; Liang J; Feng D; Deng F; Yang Y; Lu Y; Hu Z PLoS One; 2018; 13(7):e0199373. PubMed ID: 29995907 [TBL] [Abstract][Full Text] [Related]
20. Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS. Xing Y; Lai J; Liu X; Zhang N; Ming J; Liu H; Zhang X J Mol Endocrinol; 2017 May; 58(4):167-177. PubMed ID: 28250059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]